These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20421430)

  • 1. Glucoregulatory hormones and choice of osmotic agent in peritoneal dialysis.
    Mujais S; Tapiawala SN; Yip P; Al-Rowaie F; Burdzy D; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2010; 30(6):626-32. PubMed ID: 20421430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
    Arfeen S; Goodship TH; Kirkwood A; Ward MK
    Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
    Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study.
    Jones M; Hagen T; Boyle CA; Vonesh E; Hamburger R; Charytan C; Sandroni S; Bernard D; Piraino B; Schreiber M; Gehr T; Fein P; Friedlander M; Burkart J; Ross D; Zimmerman S; Swartz R; Knight T; Kraus A; McDonald L; Hartnett M; Weaver M; Martis L; Moran J
    Am J Kidney Dis; 1998 Nov; 32(5):761-9. PubMed ID: 9820445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
    Armstrong VW; Creutzfeldt W; Ebert R; Fuchs C; Hilgers R; Scheler F
    Nephron; 1985; 39(2):141-5. PubMed ID: 3883205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids.
    Selby NM; Fialova J; Burton JO; McIntyre CW
    Nephrol Dial Transplant; 2007 Mar; 22(3):870-9. PubMed ID: 17121785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R; Keller U
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal transport during dialysis with amino acid-based solutions.
    Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
    Perit Dial Int; 1993; 13(4):280-8. PubMed ID: 8241328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure.
    Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; García-Naveiro R; Isidro ML; Villaverde P; García-Buela J
    Kidney Int; 2005 Dec; 68(6):2877-85. PubMed ID: 16316365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
    Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
    J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of whole-body vibration exercise on the endocrine system of healthy men.
    Di Loreto C; Ranchelli A; Lucidi P; Murdolo G; Parlanti N; De Cicco A; Tsarpela O; Annino G; Bosco C; Santeusanio F; Bolli GB; De Feo P
    J Endocrinol Invest; 2004 Apr; 27(4):323-7. PubMed ID: 15233550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis.
    Qamar IU; Secker D; Levin L; Balfe JA; Zlotkin S; Balfe JW
    Perit Dial Int; 1999; 19(3):237-47. PubMed ID: 10433160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
    van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
    Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.